Ernexa Therapeutics Inc. Gains 47.45%
Wed, May 06, 2026 at 07:50 PM
Ernexa Therapeutics Inc. (ERNA:NASDAQ) jumped higher at $6.04, a gain of 47.4%. On Wed, May 06, 2026, ERNA:NASDAQ hit a New 2-Week High of $6.04. The stock got featured on our News Catalysts scanner on Wed, May 06, 2026 at 01:49 PM in the 'BIOTECH' category. From Wed, Apr 22, 2026, the stock recorded 40.00% Up Days and 18.18% Green Days
The stock spiked on Wed, May 06, 2026 at $7.7 with a volume of 63M+.
About Ernexa Therapeutics Inc. (ERNA:NASDAQ)
Brooklyn ImmunoTherapeutics Inc is a clinical-stage biopharmaceutical company. It is developing IRX-2, a novel hd-IL-2 -based therapy, to treat patients with cancer.
Top 10 Gainers:
- Smart for Life, Inc. (SMFL:NASDAQ), 100%
- Star Fashion Culture Holdings Limited (STFS:NASDAQ), 96.53%
- Powell Max Limited (PMAX:NASDAQ), 95.28%
- Entravision Communications Corporation (EVC:NYSE), 93.22%
- One Stop Systems, Inc. (OSS:NASDAQ), 56.91%
- Ernexa Therapeutics Inc. (ERNA:NASDAQ), 47.45%
- Ambitions Enterprise Management Co. L.L.C (AHMA:NASDAQ), 45.45%
- Bloomin' Brands, Inc. (BLMN:NASDAQ), 40.97%
- Flex Ltd. (FLEX:NASDAQ), 39.69%
- Direxion Daily AMD Bull 2X Shares (AMUU:NASDAQ), 36.54%